Observational studyScientific reports2025
Performance of machine learning models for predicting high-severity symptoms in multiple sclerosis.
Observational study in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Big data in multiple sclerosis.Current opinion in neurology · 2026Review
- Machine learning-based integration of respiratory oscillometry and spirometry for predicting clinical outcomes in spinal muscular atrophy.European journal of pediatrics · 2026Article
- Real-time breath analysis for COPD risk assessment in smokers using a ZnO/SnO₂ heterojunction sensor integrated with support vector machine.Scientific reports · 2026Article
- SeruNet-MS: A Two-Stage Interpretable Framework for Multiple Sclerosis Risk Prediction with SHAP-Based Explainability.Neurology international · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Current care in multiple sclerosis (MS) primarily relies on infrequently obtained data such as magnetic resonance imaging, clinical laboratory tests or clinical history, resulting in subtle changes that may occur between visits being missed. Mobile technology enables continual collection of data and can pave the path for predicting complex aspects of MS such as symptoms and disease courses. To this end, we conducted a first-of-its-kind observational study called MS Mosaic. First, we developed and publicly launched a mobile app for collecting longitudinal data from MS subjects in the United States. Second, we ran the study across 3 years in order to capture complex patterns for this slow progressing disease. Finally, we retrospectively developed three classical ML methods and two deep learning models to accurately and continually predict the incidence of five high-severity symptoms (fatigue, sensory disturbance, walking instability, depression or anxiety and cramps/spasms) three months in advance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.